Drug Shortage Report for TRILEPTAL 300 MG
| Report ID | 175426 |
| Drug Identification Number | 02242068 |
| Brand name | TRILEPTAL 300 MG |
| Common or Proper name | TRILEPTAL 300MG 5X10 |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | OXCARBAZEPINE |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 5x10 |
| ATC code | N03AF |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-11-25 |
| Actual start date | 2023-01-19 |
| Estimated end date | 2023-01-31 |
| Actual end date | 2023-02-03 |
| Shortage status | Resolved |
| Updated date | 2023-04-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-04-13 | French | Compare |
| v4 | 2023-04-13 | English | Compare |
| v3 | 2022-11-26 | English | Compare |
| v2 | 2022-11-22 | French | Compare |
| v1 | 2022-11-22 | English | Compare |
Showing 1 to 5 of 5